Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones

Virology

Volumn 307, Issue 2, 2003, Pages 328-340

  Bagnarelli, Patrizia ^a   Fiorelli, Lara ^a   Vecchi, Manuela ^a   Monachetti, Alessia ^a   Menzo, Stefano ^a   Clementi, Massimo ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120;

AMINO ACID SEQUENCE; ARTICLE; CHIMERA; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MODEL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; VIRUS INFECTIVITY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037444418     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00077-6     Document Type: Article

References (45)

1. Bagnarelli P., Mazzola F., Menzo S., Montroni M., Butini L., Clementi M. Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J. Virol. 73:1999;3764-3777.
2. Bagnarelli P., Valenza A., Menzo S., Sampaolesi R., Varaldo P.E., Butini L., Montroni M., Perno C.F., Aquaro S., Mathez D., Leibowitch J., Balotta C., Clementi M. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J. Virol. 70:1996;7603-7613.
3. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors roles in viral entry, tropism spazio and disease . Annu. Rev. Immunol. 17:1999;657-700.
4. Berger E.A. HIV entry and tropism the chemokine receptor connection . AIDS. 11:1997;S3-S16.
5. Carrillo A., Ratner L. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines role of V3 loop and C4 envelope determinants . J. Virol. 70:1996;1301-1309.
6. Cocchi F., DeVico A.L., Garzino-Demo A., Cara A., Gallo R.C., Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1996;1244-1247.
7. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:1997;621-628.
8. de Jong J.J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992;757-765.
9. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:1997;151-178.
10. Domingo E. Viruses at the edge of adaptation. Virology. 270:2000;251-253.
11. Este J.A., Cabrera C., Blanco J., Gutierrez A., Bridger G., Henson G., Clotet B., Schols D., De Clerca E. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype-inducing phenotype by blockade of CXCR4. J. Virol. 73:1999;5577-5585.
12. Fouchier R.A., Brouwer M., Broersen S.M., Schuitemaker H. Simple determination ofhuman immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 33:1995;906-911.
13. Freed E.O., Martin M.A. HIV infection of non-dividing cells. Nature. 369:1994;107-108.
14. Gorry P.R., Zhang C., Wu S., Kunstman K., Trachtemberg E., Phair J., Wolinsky S., Gabuzda D. Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5D32 allele. Lancet. 359:2002;1832-1834.
15. Hill C.M., Deng H., Unutmaz D., Kewalramani V.N., Bastiani L., Gorny M.K., Zolla-Pazner S., Littman D.R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:1997;6296-6304.
16. Hoffman T.L., Doms R.W. HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol. Membr. Biol. 16:1999;67-75.
17. Hu Q.X., Barry A.P., Wang Z.X., Connolly S.M., Peiper S.C., Greenberg M.L. Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J. Virol. 74:2000;11858-11872.
18. Hung C.S., Vander Heyden N., Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 73:1999;8216-8226.
19. Kato K., Sato H., Takebe Y. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. J. Virol. 73:1999;5520-5526.
20. Kuhmann S.E., Platt E.J., Kozak S.L., Kabat D. Cooperation of multiple CCR coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74:2000;7005-7015.
21. Menzo S., Sampaolesi R., Vicenzi E., Santagostino E., Liuzzi G., Chirianni A., Piazza M., Cohen O.J., Bagnarelli P., Clementi M. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. AIDS. 12:1998;985-997.
22. Moore J.P., Trkola A., Dragic T. Coreceptors for HIV-1 entry. Curr. Opin. Immunol. 9:1997;551-562.
23. Mosier D.E., Picchio G.R., Gulizia R.J., Sabbe R., Poignard P., Picard L., Ófford R.E., Thompson D.A., Wilken J. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J. Virol. 73:1999;3544-3550.
24. Ogert R.A., Lee M.K., Ross A., Bucler-Withe M., Martin A., Cho M.W. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dual-tropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 75:2001;5998-6006.
25. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infection by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;2855-2864.
26. Rizzuto C., Sodroski J. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retroviruses. 16:2000;741-749.
27. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
28. Ross T.M., Cullen B.R. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc. Natl. Acad. Sci. USA. 95:1998;7682-7686.
29. Salvatori F., Masiero S., Giaquinto C., Wade C.M., Brown A.J., Chieco-Bianchi L., De Rossi A. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J. Virol. 71:1997;4694-4706.
30. Sato H., Shiino T., Kodama N., Taniguchi K., Tomita Y., Kato K., Miyakuni T., Takebe Y. Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical transmission in a single family. J. Virol. 73:1999;3551-3559.
31. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E.M., Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1997;1259-1265.
32. Shankarappa R., Gupta P., Learn G.H., Rodrigo A.G., Rinaldo C.R., Gorry M.C., Mullins J.I., Nara P.L., Ehrlich G.D. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology. 241:1998;251-259.
33. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:1999;10489-10502.
34. Shiino T., Kato K., Kodaka N., Mijakuni T., Takebe Y., Sato H. A group of V3 sequences of human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR-5-using variants are resistant to positive selection pressure. J. Virol. 74:2000;1069-1078.
35. Smyth R.J., Yi Y., Singh A., Collman R.G. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J. Virol. 72:1998;4478-4484.
36. Sodroski J.G. HIV-1 entry inhibitors in the side pocket. Cell. 99:1999;243-246.
37. Taplitz R.A., Coffin J.M. Selection of an avian retrovirus mutant with extended receptor usage. J. Virol. 71:1997;781-789.
38. Wang W.K., Dudek T., Essex M., Lee T.H. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization therapeutic and prophylactic implications . Proc. Natl. Acad. Sci. USA. 96:1999;4558-4562.
39. Wang W.K., Dudek T., Zhao Y.J., Brumblay H.G., Essex M., Lee T.H. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proc. Natl. Acad. Sci. USA. 95:1998;5740-5745.
40. Wolinsky S.M., Korber B.T.M., Neumann A.U., Daniels M., Kuntsman K.J., Whetsell A.J., Furtado M.R., Cao Y., Ho D.D., Safrit J.T., Koup R.A. Adaptive evolution of HIV-1 during the natural course of infection. Science. 272:1996;537-542.
41. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
42. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins fusogens, antigens immunogens . Science. 280:1998;1884-1888.
43. Yamaguchi Y., Gojobori T. Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA. 94:1997;1264-1269.
44. Yamaguchi-Kabata Y., Gojobori T. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J. Virol. 74:2000;4335-4350.
45. Zhang W., Canziani G., Plugariu C., Wyatt R., Sodroski J., Sweet R., Kwong P., Hendrickson W., Chaiken I. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry. 38:1999;9405-9416.